Siemens, Other Top Dx Firms Wax Molecular At AACC Lab Conference
This article was originally published in The Gray Sheet
Executive Summary
Siemens bought its way to the top of the in vitro diagnostics market during the past two years and is now aiming to make gains in one of the fastest growing segments of that sector - molecular diagnostics
You may also be interested in...
Abbott Diagnostics Unit Teams Up With Big Pharma On Companion Test
Abbott's molecular diagnostics business announced March 7 a collaboration with Genentech, Roche and OSI Pharmaceuticals to develop a gene test that helps select patients more likely to respond to the lung cancer drug Tarceva
Ibis Prepares Next-Gen Microorganism Detector For Diagnostic Space
Five years ago the U.S. Department of Defense commissioned California-based Isis Pharmaceuticals to develop a new technology to more easily detect bioterrorism agents. Now, $55.6 million in government grants later, the company is readying the Ibis T5000 Biosensor System to make its way into the in vitro diagnostics space
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.